ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

2,3,4-トリクロロ-1,1'-ビフェニル

2,3,4-Trichlorobiphenyl

HCID 41541
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
25323-68-6
標準SMILES
Clc1ccc(-c2ccccc2)c(Cl)c1Cl
InChIKey
IUYHQGMDSZOPDZ-UHFFFAOYSA-N
分子式
C12H7Cl3
平均分子量
257.5 g/mol
単同位体質量
255.961333

概要

2,3,4-trichlorobiphenyl is a trichlorobiphenyl that is biphenyl in which the hydrogens at positions 2, 3, and 4 on one of the benzene rings are replaced by chlorines. It is a trichlorobenzene and a trichlorobiphenyl.

名称と識別子

優先名称
2,3,4-Trichlorobiphenyl
IUPAC
1,2,3-trichloro-4-phenylbenzene
現地名
2,3,4-トリクロロ-1,1'-ビフェニル
英語名
2,3,4-TRICHLOROBIPHENYL
分子式
C12H7Cl3
分子量
257.54

名称と別名

2,3,4-Trichlorobiphenyl55702-46-02,3,4-TRICHLORO-1,1'-BIPHENYLPCB 211,1'-Biphenyl, 2,3,4-trichloro-UNII-61NYE2032D61NYE2032DDTXSID0074180CHEBI:34222RefChem:53570DTXCID3041950TRICHLOROBIPHENYL
名称をさらに表示
2,3,4-トリクロロ-1,1'-ビフェニル2,3,4-トリクロロビフェニル2,3,4‐トリクロロビフェニル標準品2,3,4‐トリクロロビフェニル標準液2,3,4-トリクロロビフェニル, 100 µg/mL in Isooctane2,3,4-トリクロロ-1,1′-ビフェニルPCB-212,3,4-トリクロロビフェニル標準液BZNO 212,3,4-CBPCB NO 212,3,4-Trichlorobiphenyl-d5PCB No. 21 10 μg/mL in IsooctanePCB NO.21-2,3,4-Trichlorobiphenyl234TRICHLOROBIPHENYL(2,3,4-TRICHLOROISOMER)
25323-68-61,2,3-trichloro-4-phenylbenzenePCB No. 21TrichlorodiphenylBiphenyl, trichloro-Apirolio 1431 CPyranol 1499Trichloro-1,1'-biphenyl

データベース識別子

物性

構造計算による物性

XLogP
5.9
極性表面積
0 Ų
水素結合供与体数
0
水素結合受容体数
0
回転可能結合数
1
重原子数
15
形式電荷
0
複雑度
201

実験および物理化学的性質

SpringerMaterials Properties13C nuclear magnetic resonance spectrum
LogP5.68
Endocrine DisruptorsPotential endocrine disrupting compound

物理化学的性質

融点
102 °C · 102°C
沸点
334.36 °C · 334.36°C (rough estimate)
比重(密度)
1.351 · 1.3510 (rough estimate)
屈折率
1.604 · 1.6040 (rough estimate)
Henry's Law Constant
4.3 · 4.3×10-3 mol/(m3Pa) at 25℃, Paasivirta and Sinkkonen (2009)
CAS データベース
55702 · 55702-46-0
EPAの化学物質情報
2 · 2,3,4-Trichlorobiphenyl (55702-46-0)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 3 件

This chemical does not meet GHS hazard criteria for 100% (3 of 3) of all reports.

Not Classified

Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesNot Classified

安全と保護具

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

毒性情報

Treatment · 1 件

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 件

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Exposure RoutesOral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 件

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

用途と製造

Uses · 1 件

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

応用分野

使用2,3,4-Trichlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

上流・下流製品情報

下流製品

3,4-ジクロロ[1,1'-ビフェニル]

補足説明

定義ChEBI: A trichlorobiphenyl that is biphenyl in which the hydrogens at positions 2, 3, and 4 on one of the benzene rings are replaced by chlorines.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
CAS
25323-68-6、55702-46-0
PubChem CID
41541
DTXSID
DTXSID0074180
ChEBI
CHEBI:34222
UNII
61NYE2032D
EC Number
690-243-4
Nikkaji
J150.405C
Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

安全データ

化審法
-1
安衛法
特定化学物質障害予防規則:第1類物質,57,57-2
消防法
危-4-1-II